Literature DB >> 17197177

Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors.

Francis Beaulieu1, Carl Ouellet, Edward H Ruediger, Makonen Belema, Yuping Qiu, Xuejie Yang, Jacques Banville, James R Burke, Kurt R Gregor, John F MacMaster, Alain Martel, Kim W McIntyre, Mark A Pattoli, F Christopher Zusi, Dolatrai Vyas.   

Abstract

We have recently identified BMS-345541 (1) as a highly selective and potent inhibitor of IKK-2 (IC50 = 0.30 microM), which however was considerably less potent against IKK-1 (IC50 = 4.0 microM). In order to further explore the SAR around the imidazoquinoxaline tricyclic structure of 1, we prepared a series of tetracyclic analogues (7, 13, and 18). The synthesis and biological activities of these potent IKK inhibitors are described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197177     DOI: 10.1016/j.bmcl.2006.12.017

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Inhibitory kappa B Kinases as targets for pharmacological regulation.

Authors:  Carly Gamble; Kathryn McIntosh; Rebecca Scott; Ka Ho Ho; Robin Plevin; Andrew Paul
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  3D QSAR pharmacophore model based on diverse IKKβ inhibitors.

Authors:  Shanthi Nagarajan; Asif Ahmed; Hyunah Choo; Yong Seo Cho; Kwang-Seok Oh; Byung Ho Lee; Kye Jung Shin; Ae Nim Pae
Journal:  J Mol Model       Date:  2010-04-25       Impact factor: 1.810

3.  IKKβ inhibitor identification: a multi-filter driven novel scaffold.

Authors:  Shanthi Nagarajan; Hyunah Choo; Yong Seo Cho; Kye Jung Shin; Kwang-Seok Oh; Byung Ho Lee; Ae Nim Pae
Journal:  BMC Bioinformatics       Date:  2010-10-15       Impact factor: 3.169

4.  Identification of human IKK-2 inhibitors of natural origin (part I): modeling of the IKK-2 kinase domain, virtual screening and activity assays.

Authors:  Esther Sala; Laura Guasch; Justyna Iwaszkiewicz; Miquel Mulero; Maria-Josepa Salvadó; Montserrat Pinent; Vincent Zoete; Aurélien Grosdidier; Santiago Garcia-Vallvé; Olivier Michielin; Gerard Pujadas
Journal:  PLoS One       Date:  2011-02-24       Impact factor: 3.240

5.  Kinase inhibitors for the treatment of inflammatory and autoimmune disorders.

Authors:  Shripad S Bhagwat
Journal:  Purinergic Signal       Date:  2008-06-21       Impact factor: 3.765

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.